Third Party Storage Of Electronic Clinical Data Suggested By PhRMA
This article was originally published in The Tan Sheet
Executive Summary
FDA should permit electronic storage of clinical data by third parties, the Pharmaceutical Research & Manufacturers of America says in comments on the agency's 1Part 11 electronic records draft guidance
You may also be interested in...
Electronic Records Enforcement Relaxed During Part 11 Review, FDA Says
FDA intends to relax enforcement of its Part 11 regulation on electronic records while it reexamines the rule's application, a 1draft guidance published Feb. 25 states
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands